trimethylamine testing at sheffield children’s hospital...2018/03/19 · summary of reporting...
TRANSCRIPT
Trimethylamine testing at Sheffield Children’s Hospital
Joanne Croft, Clinical Scientist Edwin Smith, Medical Technical Officer
01/03/2018
Sample Reception
pH
Dipstick / indicator paper
Volatile TMA stabilised as HCl salt
Nitrite
Dipstick
Positive result indicates bacterial
contamination
Exclude UTI and repeat sample
Creatinine
Standardisation of results on dilute
/ concentrated urine
Storage: -80C
Initial tests
Analysis
Free Trimethylamine (TMA) Odourous compound
Trimethylamine-N-Oxide
(TMANO) Non-odourous
TMANO not measured directly Converted to TMA
Total TMA measured TMA + TMANO
Subtract free TMA to give
TMANO
What do we measure and how?
Analysis
Alkalinisation Addition of KOH converts
TMA.HCl to volatile TMA
Reduction TiCl3 converts TMANO to
TMA
Followed by alkalinisation
as above
Sample Preparation
Analysis
Headspace GCMS
Analysis
Headspace sampler Samples volatile gas from
“headspace” above liquid phase
Gas Chromatograph Separates compounds using
liquid coated capillary column
Mass Spectrometer Ionises compounds and detects
on basis of mass to charge ratio
Headspace GC-MS
Analysis
Data gives free and total TMA in µmol/L
Divide by creatinine to give results in
µmol/mmol crt
Subtract free from total TMA to give TMANO
Ratio of TMANO to total TMA gives % N-
oxidation
Result calculation
Analysis
Data analysis
TMA
Analysis
Quantitative Free TMA
TMANO
% N-oxidation
Interpretive For a non-specialist doctor
Relies on knowing clinical
details
Reporting
Quality
Quality Covers all aspects of the
laboratory
Assay validation
Internal quality control
Quality Assurance / Sample
exchange
UKAS accreditation
How can we know our result is correct?
Quality
Must be completed before
assay put into routine use
Signed off by manager / HoD
Covers technical performance
of assay Sensitivity
Specificity
Precision
Linearity
Assay Validation
Quality
Reference ranges Assay dependent
From literature as starting point
Masschke et al
TMA 7.7µmol/mmol crt
TMANO 119µmol/mmol crt
N-oxidation 94%
Verified in laboratory
37 samples from unaffected individuals
Mean TMA 0.82µmol/mmol crt (range 0.23 – 3.13)
Mean N-oxidation 98% (range 81 – 100)
Assay Validation
Quality
Sample exchange programme Four participating laboratories worldwide
Children’s Hospital Colorado
LC-MSMS
Radboud UMC Nijmegen
1H-NMR
UniversitätsKlinikum Heidelberg
SPME-GCMS
Sheffield Children’s Hospital
HS-GCMS
Two distributions per year
Five samples per distribution
Scheme begun February 2016
Good performance so far
External Quality Assurance
(EQA)
Quality
United Kingdom Accreditation Service
(UKAS)
ISO15189 – Medical laboratories –
requirements for quality and competence International standards
Cover all aspects of laboratory work
Recent inspection Observed assay being performed
SOPs
Training records / competencies
IQC / EQA
Reporting
Laboratory accreditation
Results
One year on
Trimethylamine testing
Results
Assay running for one year n = 725
Includes repeat samples and monitoring patients,
including those on treatment
147 results below limit of quantitation
Very low levels, unable to provide quantitative result
453 results within ref range for TMA and N-oxidation
94 results outside ref ranges for TMA and N-oxidation
8 results outside ref range for TMA, within ref range
for N-oxidation
23 results within ref range for TMA, outside ref range
for N-oxidation
Mainly known patients on dietary restriction
Feb 2017 – Jan 2018
Results for first year
Interpreting TMA results
Important to note:
Results from the ‘old’ method cannot be directly
compared to those using our ‘new’ method
Results obtained by our method cannot be
interpreted using other laboratories reference ranges
(such as those quoted on scientific papers)
Updated TMAU assay
Values reported and reference ranges:
Reference range Units
Free TMA:creatinine ratio < 7.7 µmol/mmol
creatinine
TMA-N-Oxide:creatinine
ratio
< 119 µmol/mmol
creatinine
% Oxidation > 94 %
Urine creatinine N/A mmol/L
These were originally taken from a paper – we are now confident that these
ranges are correct for our assay.
Summary of reporting
This assay is a ‘screen’
There is much interplay between enzyme activity,
diet, gut flora and hormones
There can be intra-individual variation of results
Clinical details provided are often lacking
For a definitive diagnosis of Primary
Trimethylaminuria genetic testing is required
Summary
Trimethylamine testing requires much expertise
and specialist (expensive!) equipment
Sample exchange scheme set up and showing
good agreement of results between laboratories
Reporting of results of new assay at SCH now
finalised